bromfenac has been researched along with Intraocular Pressure in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (25.00) | 29.6817 |
| 2010's | 12 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Awadi, A; Chan, CC; Somani, S; Tokko, HA | 1 |
| Guo, N; Liu, J; Wang, MM; Xu, Y; Zhang, FJ; Zhang, QL; Zhao, X; Zheng, Y | 1 |
| Earnest, D; Ellis, D; Hamilton, G; Jacobson, N; Katoli, P; Kelly, CR; Klekar, L; Li, L; Sharif, NA; Shepard, AR; Wang, Y; Xu, S; Yacoub, S | 1 |
| Brookshire, HL; English, RV; Gift, BW; Gilger, BC; Nadelstein, B; Weigt, AK | 1 |
| Mazur-Piotrowska, G; Piotrowska-Gwóźdź, A; Piotrowska-Seweryn, A; Rokicki, W; Wyględowska-Promieńska, D | 1 |
| Aihara, M; Matsuo, H; Miyata, K; Sakata, R; Sakisaka, T | 1 |
| Chen, S; Jiang, Y; Li, Y; Yu, C | 1 |
| Chen, HH; Dean, TR; Glennon, RA; Hellberg, MR; Holt, WF; Kelly, CR; May, JA; McLaughlin, MA; Severns, BS; Sharif, NA; Young, R | 1 |
| Bansal, R; Gupta, A; Pandav, SS; Ram, J; Sahu, S | 1 |
| Jiang, Y; Jin, YM; Li, Y; Zhang, JY | 1 |
| Kato, S; Maruyama, Y; Miyai, T; Miyanaga, M; Miyata, K; Nejima, R | 1 |
| Endo, N; Haruyama, K; Kato, S; Kitano, S; Shoji, M | 1 |
| Holland, EJ; Lane, SS | 1 |
| Kashiwagi, K; Tsukahara, S | 1 |
| Donnenfeld, ED; Gow, JA; Grillone, LR; Holland, EJ; Stewart, RH | 1 |
| Donnenfeld, ED; Gow, JA; Grillone, LR; Shiffman, ML; Stewart, RH | 1 |
12 trial(s) available for bromfenac and Intraocular Pressure
| Article | Year |
|---|---|
Comparison of 2 regimens of loteprednol etabonate and bromfenac for cataract surgery.
Topics: Aged; Anti-Allergic Agents; Anti-Inflammatory Agents, Non-Steroidal; Benzophenones; Bromobenzenes; Cataract Extraction; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Intraocular Pressure; Intraoperative Period; Loteprednol Etabonate; Male; Ophthalmic Solutions; Patient Satisfaction; Postoperative Complications; Prospective Studies; Time Factors; Treatment Outcome; Visual Acuity | 2019 |
[The clinical efficacy of 0.1% bromfenac sodium hydrate ophthalmic solution after excimer laser in situ keratomileusis].
Topics: Adolescent; Adult; Benzophenones; Bromobenzenes; Female; Fluorometholone; Humans; Intraocular Pressure; Keratomileusis, Laser In Situ; Male; Myopia; Ophthalmic Solutions; Postoperative Period; Treatment Outcome; Young Adult | 2013 |
Combination of bevacizumab and bromfenac therapy in age-related macular degeneration: a pilot study.
Topics: Aged; Antibodies, Monoclonal, Humanized; Benzophenones; Bevacizumab; Bromobenzenes; Case-Control Studies; Drug Therapy, Combination; Female; Humans; Intraocular Pressure; Macular Degeneration; Male; Pilot Projects; Retina; Subretinal Fluid; Tomography, Optical Coherence; Visual Acuity | 2014 |
Time Course of Prostaglandin Analog-related Conjunctival Hyperemia and the Effect of a Nonsteroidal Anti-inflammatory Ophthalmic Solution.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antihypertensive Agents; Benzophenones; Bromobenzenes; Conjunctiva; Conjunctival Diseases; Double-Blind Method; Female; Humans; Hyperemia; Intraocular Pressure; Male; Middle Aged; Ophthalmic Solutions; Prospective Studies; Time Factors; Travoprost; Young Adult | 2016 |
[Comparison of clinical effects of bromfenac sodium ophthalmic solution 0.1% versus glucocorticoids for post-LASEK usage].
Topics: Benzophenones; Bromobenzenes; Corneal Topography; Dexamethasone; Drug Administration Schedule; Dry Eye Syndromes; Fluorometholone; Glucocorticoids; Humans; Intraocular Pressure; Keratectomy, Subepithelial, Laser-Assisted; Ophthalmic Solutions; Postoperative Period; Prospective Studies; Statistics, Nonparametric; Surgical Flaps; Tonometry, Ocular; Visual Acuity | 2015 |
Effect of topical ketorolac 0.4%, nepafenac 0.1%, and bromfenac 0.09% on postoperative inflammation using laser flare photometry in patients having phacoemulsification.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Benzophenones; Bromobenzenes; Endophthalmitis; Female; Humans; Intraocular Pressure; Ketorolac; Lens Implantation, Intraocular; Male; Middle Aged; Ophthalmic Solutions; Phacoemulsification; Phenylacetates; Photometry; Postoperative Complications; Prospective Studies; Visual Acuity | 2015 |
Effect of bromfenac ophthalmic solution on ocular inflammation following cataract surgery.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Aqueous Humor; Benzophenones; Betamethasone; Bromobenzenes; Cataract Extraction; Cornea; Drug Therapy, Combination; Endophthalmitis; Endothelium, Corneal; Female; Humans; Intraocular Pressure; Lens Implantation, Intraocular; Macular Edema; Male; Middle Aged; Ophthalmic Solutions; Postoperative Period; Tomography, Optical Coherence; Treatment Outcome; Visual Acuity | 2009 |
Efficacy of bromfenac sodium ophthalmic solution in preventing cystoid macular oedema after cataract surgery in patients with diabetes.
Topics: Adult; Aged; Aged, 80 and over; Anterior Chamber; Anti-Inflammatory Agents, Non-Steroidal; Benzophenones; Bromobenzenes; Diabetic Retinopathy; Female; Glucocorticoids; Humans; Intraocular Pressure; Lens Implantation, Intraocular; Macular Edema; Male; Middle Aged; Ophthalmic Solutions; Phacoemulsification; Postoperative Complications; Prospective Studies; Tomography, Optical Coherence; Treatment Outcome; Uveitis, Anterior; Visual Acuity | 2010 |
Loteprednol etabonate 0.5% versus prednisolone acetate 1.0% for the treatment of inflammation after cataract surgery.
Topics: Adult; Aged; Aged, 80 and over; Androstadienes; Anterior Chamber; Anti-Allergic Agents; Anti-Inflammatory Agents, Non-Steroidal; Azepines; Benzophenones; Bromobenzenes; Cataract Extraction; Double-Blind Method; Drug Therapy, Combination; Female; Fluoroquinolones; Glucocorticoids; Humans; Inflammation; Intraocular Pressure; Loteprednol Etabonate; Male; Middle Aged; Ophthalmic Solutions; Postoperative Complications; Prednisolone; Topoisomerase II Inhibitors; Uveitis, Anterior; Visual Acuity | 2013 |
Effect of non-steroidal anti-inflammatory ophthalmic solution on intraocular pressure reduction by latanoprost.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antihypertensive Agents; Benzophenones; Bromobenzenes; Drug Administration Schedule; Drug Interactions; Fluorescein Angiography; Humans; Intraocular Pressure; Latanoprost; Male; Ophthalmic Solutions; Prospective Studies; Prostaglandins F, Synthetic | 2003 |
Bromfenac ophthalmic solution 0.09% (Xibrom) for postoperative ocular pain and inflammation.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Benzophenones; Bromobenzenes; Cataract Extraction; Double-Blind Method; Female; Humans; Inflammation; Intraocular Pressure; Lens Implantation, Intraocular; Male; Middle Aged; Ophthalmic Solutions; Pain, Postoperative; Treatment Outcome; Uveitis, Anterior; Visual Acuity | 2007 |
The systemic safety of bromfenac ophthalmic solution 0.09%.
Topics: Aged; Anterior Eye Segment; Benzophenones; Bromobenzenes; Cataract Extraction; Drug-Related Side Effects and Adverse Reactions; Female; Follow-Up Studies; Humans; Instillation, Drug; Intraocular Pressure; Lens Implantation, Intraocular; Liver Function Tests; Male; Ophthalmic Solutions; Pain, Postoperative; Phacoemulsification; Placebos; Self Administration; Treatment Outcome; Visual Acuity | 2007 |
4 other study(ies) available for bromfenac and Intraocular Pressure
| Article | Year |
|---|---|
Trabecular meshwork bradykinin receptors: mRNA levels, immunohistochemical visualization, signaling processes pharmacology, and linkage to IOP reduction.
Topics: Aged; Animals; Benzophenones; Bradykinin; Bradykinin B2 Receptor Antagonists; Bromobenzenes; Female; Humans; Immunohistochemistry; Intraocular Pressure; Kininogens; Macaca fascicularis; Male; Naphthalenes; Organophosphorus Compounds; Prostaglandins; Rabbits; Receptor, Bradykinin B2; Receptors, Bradykinin; RNA, Messenger; Signal Transduction; Trabecular Meshwork | 2014 |
Efficacy of COX-2 inhibitors in controlling inflammation and capsular opacification after phacoemulsification cataract removal.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzophenones; Bromobenzenes; Celecoxib; Cyclooxygenase 2 Inhibitors; Dog Diseases; Dogs; Inflammation; Intraocular Pressure; Lenses, Intraocular; Phacoemulsification; Prednisolone | 2015 |
Ocular Hypotensive Response in Nonhuman Primates of (8R)-1-[(2S)-2-Aminopropyl]-8,9-dihydro-7H-pyrano[2,3-g]indazol-8-ol a Selective 5-HT2 Receptor Agonist.
Topics: Administration, Topical; Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzophenones; Bromobenzenes; Cornea; Glaucoma; HT29 Cells; Humans; In Vitro Techniques; Indazoles; Indicators and Reagents; Intraocular Pressure; Macaca fascicularis; Ocular Hypertension; Permeability; Rats; Receptors, Adrenergic, alpha; Receptors, Serotonin; Serotonin 5-HT2 Receptor Agonists; Structure-Activity Relationship | 2015 |
[Comparison of the effects of 0.1% bromfenac sodium eye drops and corticosteroids after small incision lenticule extraction].
Topics: Adrenal Cortex Hormones; Anti-Bacterial Agents; Benzophenones; Bromobenzenes; Case-Control Studies; Corneal Topography; Dexamethasone; Drug Administration Schedule; Female; Humans; Intraocular Pressure; Male; Myopia; Ophthalmic Solutions; Prospective Studies; Tobramycin; Tonometry, Ocular; Visual Acuity | 2017 |